Targeting NSCLC with Precision: Evaluation of the Emerging Role of Antibody-Drug Conjugates - Episode 3
Exploring the TROPION-Lung04 Study July 2, 2024
Mark A. Socinski, MD , Helena A. Yu, MD , Zosia Piotrowska, MD, MHS , Julia Rotow, MD , Benjamin Levy, MD
Benjamin Levy, MD, presents an overview of the TROPION-Lung04 study in the first-line setting, focusing on the toxicity profile and potential impact on clinical practice.
Please review the TROPION-Lung04 study in 1L setting. (Papadoupoulos et al. WCLC 2023 )Briefly outline the study design and key endpoints and discuss the rationale for this treatment approach. What implications may these findings have on clinical practice Moderator followed up on ADC toxicities